logo-loader

Cano Health’s cash flow challenges spark analyst ‘sell’ rating

Published: 15:54 17 Nov 2023 EST

Cano Health

Cano Health Inc’s cash flow challenges appear "daunting" as the primary care provider’s recent quarterly losses swelled, according to UBS analysts. 

In an update to clients, they downgraded Cano stock from ‘Neutral’ to a ‘Sell’, while slashing its price target to $3.75 per share from $12 previously, as the analysts believe elevated third-party medical expenses will have a sustained negative effect on the company's already challenged liquidity position. 

They also noted Cano's recent third-quarter financial results continue to disappoint, with the company’s cash flow and liquidity situation still deteriorating.   

Analysts at UBS added that Cano’s liquidity as of November 9, 2023, was $53 million of cash and equivalents with no capacity remaining on its revolving credit line.  

During its past two quarterly reports, Cano stated that "there is substantial doubt about the company's ability to continue as a going concern within one year," and it continues to explore its strategic options.

Shares of Cano Health slipped 6% to $7.68 in late-day trading on Friday and have plunged 93% year to date. 

Contact Sean at sean@proactiveinvestors.com 

Arrow Exploration CEO on Icaco success, record production and next drilling...

Arrow Exploration Corp (TSX-V:AXL, AIM:AXL, OTC:CSTPF) CEO Marshall Abbott talked with Proactive's Stephen Gunnion about the company's latest drilling success at Icaco in Colombia, where the IC-HZ9 well has exceeded production expectations and helped lift corporate output above 7,000 barrels of...

5 hours, 34 minutes ago